Source: The Washington Post
When Hahn later learned the effort was on behalf of the president, he was stunned. For God’s sake, he thought, it’s the president who’s sick, and you want us to bend the rules? Trump was in the highest-risk category for severe disease from covid-19 — at 74, he rarely exercised and was considered medically obese. He was the type of patient with whom you would want to take every possible precaution. As it did with all compassionate-use applications, the FDA made a decision within 24 hours. Agency officials scrambled to figure out which company’s monoclonal antibody would be most appropriate given the clinical information they had, and selected the one from Regeneron, known simply as Regen-Cov.
A five-day stretch in October 2020 — from the moment White House officials began an extraordinary effort to get Trump lifesaving drugs to the day the president returned to the White House from the hospital — marked a dramatic turning point in the nation’s flailing coronavirus response. Trump’s brush with severe illness and the prospect of death caught the White House so unprepared that they had not even briefed Vice President Mike Pence’s team on a plan to swear him in if Trump became incapacitated.
For months, the president had taunted and dodged the virus, flouting safety protocols by holding big rallies and packing the White House with maskless guests. But just one month before the election, the virus that had already killed more than 200,000 Americans had sickened the most powerful person on the planet.
The guy would have died without this extraordinary care. Instead he lives and continues to spread poison.